Phase 2 trial of oxaliplatin plus capecitabine (XELOX) as second-line therapy for patients with advanced pancreatic cancer (Q34596369)
scientific article
Language:
Current Data About Phase 2 trial of oxaliplatin plus capecitabine (XELOX) as second-line therapy for patients with advanced pancreatic cancer
(P31) (Q13442814)
(P248)
(P698) 18756532
(P813) Thursday, August 3, 2017

(P50) (Q14947937)
(P1545) 5
(P1932) James L Abbruzzese
(P248)
(P698) 18756532
(P813) Thursday, August 3, 2017

(P304) 2046-2052
(P248)
(P698) 18756532
(P813) Thursday, August 3, 2017

(P407) (Q1860)

(P433) 8
(P248)
(P698) 18756532
(P813) Thursday, August 3, 2017

(P478) 113
(P248)
(P698) 18756532
(P813) Thursday, August 3, 2017

(P577) Wednesday, October 1, 2008
(P248)
(P698) 18756532
(P813) Thursday, August 3, 2017

(P921) (Q42824440)

(Q422327)
(P887)

(Q420207)
(P887)

(Q212961)
(P887)

(P1433) (Q326041)
(P248)
(P698) 18756532
(P813) Thursday, August 3, 2017

(P1476) "Phase 2 trial of oxaliplatin plus capecitabine (XELOX) as second-line therapy for patients with advanced pancreatic cancer" (language: en)
(P248)
(P698) 18756532
(P813) Thursday, August 3, 2017

(P2093) Henry Q Xiong
(P1545) 1
(P248)
(P698) 18756532
(P813) Thursday, August 3, 2017

Gauri R Varadhachary
(P1545) 2
(P248)
(P698) 18756532
(P813) Thursday, August 3, 2017

Joan C Blais
(P1545) 3
(P248)
(P698) 18756532
(P813) Thursday, August 3, 2017

Kenneth R Hess
(P1545) 4
(P248)
(P698) 18756532
(P813) Thursday, August 3, 2017

Robert A Wolff
(P1545) 6
(P248)
(P698) 18756532
(P813) Thursday, August 3, 2017

(P2860) (Q29547565)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FCNCR.23810
(P813) Thursday, January 7, 2021
(P887)

(Q34525788)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FCNCR.23810
(P813) Thursday, January 7, 2021
(P887)

(Q33367733)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FCNCR.23810
(P813) Thursday, January 7, 2021
(P887)

(Q34557866)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FCNCR.23810
(P813) Thursday, January 7, 2021
(P887)

(Q33360410)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FCNCR.23810
(P813) Thursday, January 7, 2021
(P887)

(Q29619344)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FCNCR.23810
(P813) Thursday, January 7, 2021
(P887)

(Q27863454)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FCNCR.23810
(P813) Thursday, January 7, 2021
(P887)

(Q34579882)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FCNCR.23810
(P813) Thursday, January 7, 2021
(P887)

(Q40940997)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FCNCR.23810
(P813) Thursday, January 7, 2021
(P887)

(Q33342773)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FCNCR.23810
(P813) Thursday, January 7, 2021
(P887)

(Q60629726)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FCNCR.23810
(P813) Thursday, January 7, 2021
(P887)

(Q47365749)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FCNCR.23810
(P813) Thursday, January 7, 2021
(P887)

(Q45233598)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FCNCR.23810
(P813) Thursday, January 7, 2021
(P887)

(Q37355035)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FCNCR.23810
(P813) Thursday, January 7, 2021
(P887)

(Q44955215)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FCNCR.23810
(P813) Thursday, January 7, 2021
(P887)

(Q45148156)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FCNCR.23810
(P813) Thursday, January 7, 2021
(P887)

(Q33367224)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FCNCR.23810
(P813) Thursday, January 7, 2021
(P887)

(Q34564463)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FCNCR.23810
(P813) Thursday, January 7, 2021
(P887)

(Q33370390)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FCNCR.23810
(P813) Thursday, January 7, 2021
(P887)

(Q80656911)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FCNCR.23810
(P813) Thursday, January 7, 2021
(P887)

(Q33373896)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FCNCR.23810
(P813) Thursday, January 7, 2021
(P887)

(Q46942061)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FCNCR.23810
(P813) Thursday, January 7, 2021
(P887)

(Q37074126)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FCNCR.23810
(P813) Thursday, January 7, 2021
(P887)

other details